Prasanna M Dattatreya

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Dr. Reddy's Laboratories, Incorporated, Other. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prasanna M Dattatreya. Retrieved from https://idiyas.com/inventor/prasanna-m-dattatreya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 22(Granted Patents)

Company Filing History:

4 out of 187

Dr. Reddy's Laboratories, Incorporated

patents

1 out of 834,601

Other

patents

Years Active: 2015-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10344031 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2019-07-09),

2. 10047087 - Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibitors (2018-08-14),

3. 9670207 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2017-06-06),

4. 9402833 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2016-08-02),

5. 9045478 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2015-06-02),

Title: Innovations of Prasanna M Dattatreya

Introduction

Prasanna M Dattatreya is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds. With a total of five patents to his name, Dattatreya's work focuses on innovative solutions for medical applications.

Latest Patents

Among his latest patents are two related to substituted pyrazolo[1,5-a]pyridine compounds. These compounds are recognized for their potential as tropomyosin receptor kinase (Trk) inhibitors. The applications detail methods of making these compounds and their use in pharmaceutical compositions aimed at inhibiting the Trk family protein kinases.

Career Highlights

Dattatreya has had a distinguished career, working with prominent organizations such as Dr. Reddy's Laboratories. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative ideas into practical applications.

Collaborations

Throughout his career, Dattatreya has collaborated with various professionals, including notable coworkers like Pradip Kumar Sasmal and Shahadat Ahmed. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Prasanna M Dattatreya's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic options in medicine.

Profile summary based on public USPTO records.